TransCode Therapeutics press releases
The latest press releases from TransCode Therapeutics (NASDAQ: RNAZ), gathered from its own newsroom and from the newswires that carry it. PPN World follows 1,400+ press release feeds and adds each TransCode Therapeutics release within minutes of publication.
- Listing
- NASDAQ: RNAZ
- Latest release
- Oct 19, 2026
- On this page
- 7 newest releases
Latest TransCode Therapeutics press releases
- TransCode Therapeutics to Present Phase 1a Clinical Trial Data for TTX-MC138 at ESMO Congress 2026
Poster presentation to highlight the Phase 1a clinical evaluation of TTX-MC138 in patients with advanced solid tumors BOSTON, Oct. 19, 2026 /PRNewswire/ -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ),…
- TransCode Therapeutics Announces Patent Advancements in Australia and Japan Strengthening Global IP Position in RNA-Based Immuno-Oncology
Allowances of Patent Applications in Australia and Japan support differentiated RNA platform for targeted cancer therapy and immune modulation BOSTON, Sept. 22, 2026 /PRNewswire/ -- TransCode Therapeu…
- Join Today's Live Investor Webinar with TransCode Therapeutics
(PR-inside.com) Learn how TransCode Therapeutics is advancing RNA therapeutics, cancer vaccines, and immuno-oncology programs designed to address advanced and metastatic cancers Management to discuss…
The first 3 are open to everyone. A free account shows the rest and emails you the next TransCode Therapeutics release the minute it is out.
PPN World is independent and not affiliated with TransCode Therapeutics. Headlines and short excerpts only; each release links to its source.
Questions
Where can I find TransCode Therapeutics press releases?+
How do I get an alert when TransCode Therapeutics publishes a press release?+
Is this TransCode Therapeutics's official newsroom?+
Know the minute TransCode Therapeutics publishes
Watch TransCode Therapeutics, its competitors and its sector in one live feed, with email alerts — on the free plan.